These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 1388036)
1. Antitumour synergism between non-toxic dietary combinations of isotretinoin and glucarate. Abou-Issa H; Koolemans-Beynen A; Meredith TA; Webb TE Eur J Cancer; 1992; 28A(4-5):784-8. PubMed ID: 1388036 [TBL] [Abstract][Full Text] [Related]
2. Chemotherapeutic evaluation of glucarate and N-(4-hydroxyphenyl)retinamide alone and in combination in the rat mammary tumor model. Abou-Issa H; Webb TE; Minton JP; Moeschberger M J Natl Cancer Inst; 1989 Dec; 81(23):1820-3. PubMed ID: 2531231 [TBL] [Abstract][Full Text] [Related]
3. Putative metabolites derived from dietary combinations of calcium glucarate and N-(4-hydroxyphenyl)retinamide act synergistically to inhibit the induction of rat mammary tumors by 7,12-dimethylbenz[a]anthracene. Abou-Issa HM; Duruibe VA; Minton JP; Larroya S; Dwivedi C; Webb TE Proc Natl Acad Sci U S A; 1988 Jun; 85(12):4181-4. PubMed ID: 2967969 [TBL] [Abstract][Full Text] [Related]
4. Mechanism of growth inhibition of mammary carcinomas by glucarate and the glucarate: retinoid combination. Webb TE; Abou-Issa H; Stromberg PC; Curley RC; Nguyen MH Anticancer Res; 1993; 13(6A):2095-9. PubMed ID: 8297119 [TBL] [Abstract][Full Text] [Related]
5. Synergistic interaction between 13-cis-retinoic acid and glucarate: activity against rat mammary tumor induction and MCF-7 cells. Abou-Issa H; Koolemans-Beynen A; Minton JP; Webb TE Biochem Biophys Res Commun; 1989 Sep; 163(3):1364-9. PubMed ID: 2783140 [TBL] [Abstract][Full Text] [Related]
6. Relative efficacy of glucarate on the initiation and promotion phases of rat mammary carcinogenesis. Abou-Issa H; Moeschberger M; el-Masry W; Tejwani S; Curley RW; Webb TE Anticancer Res; 1995; 15(3):805-10. PubMed ID: 7645962 [TBL] [Abstract][Full Text] [Related]
7. Dietary glucarate as anti-promoter of 7,12-dimethylbenz[a]anthracene-induced mammary tumorigenesis. Walaszek Z; Hanausek-Walaszek M; Minton JP; Webb TE Carcinogenesis; 1986 Sep; 7(9):1463-6. PubMed ID: 3091283 [TBL] [Abstract][Full Text] [Related]
8. Growth suppression of human breast carcinoma cells in culture by N-(4-hydroxyphenyl)retinamide and its glucuronide and through synergism with glucarate. Bhatnagar R; Abou-Issa H; Curley RW; Koolemans-Beynen A; Moeschberger ML; Webb TE Biochem Pharmacol; 1991 May; 41(10):1471-7. PubMed ID: 1826840 [TBL] [Abstract][Full Text] [Related]
9. Antiproliferative effect of dietary glucarate on the Sprague-Dawley rat mammary gland. Walaszek Z; Hanausek M; Sherman U; Adams AK Cancer Lett; 1990 Jan; 49(1):51-7. PubMed ID: 2302696 [TBL] [Abstract][Full Text] [Related]
11. Enhanced inhibition of mammary carcinogenesis by combined treatment with N-(4-hydroxyphenyl)retinamide and ovariectomy. McCormick DL; Mehta RG; Thompson CA; Dinger N; Caldwell JA; Moon RC Cancer Res; 1982 Feb; 42(2):508-12. PubMed ID: 6459843 [TBL] [Abstract][Full Text] [Related]
12. Basis for the anti-tumor and chemopreventive activities of glucarate and the glucarate:retinoid combination. Abou-Issa H; Dwivedi C; Curley RW; Kirkpatrick R; Koolemans-Beynen A; Engineer FN; Humphries KA; el-Masry W; Webb TE Anticancer Res; 1993; 13(2):395-9. PubMed ID: 8517653 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics relevant to the anti-carcinogenic and anti-tumor activities of glucarate and the synergistic combination of glucarate:retinoid in the rat. Webb TE; Pham-Nguyen MH; Darby M; Hamme AT Biochem Pharmacol; 1994 Apr; 47(9):1655-60. PubMed ID: 8185680 [TBL] [Abstract][Full Text] [Related]
14. Effects of the experimental chemopreventative agent, glucarate, on intestinal carcinogenesis in rats. Dwivedi C; Oredipe OA; Barth RF; Downie AA; Webb TE Carcinogenesis; 1989 Aug; 10(8):1539-41. PubMed ID: 2752528 [TBL] [Abstract][Full Text] [Related]
15. Chemopreventive efficacy of combined retinoid and tamoxifen treatment following surgical excision of a primary mammary cancer in female rats. Ratko TA; Detrisac CJ; Dinger NM; Thomas CF; Kelloff GJ; Moon RC Cancer Res; 1989 Aug; 49(16):4472-6. PubMed ID: 2525951 [TBL] [Abstract][Full Text] [Related]
16. Synergistic effect of retinoids and interferon alpha on tumor-induced angiogenesis: anti-angiogenic effect on HPV-harboring tumor-cell lines. Majewski S; Szmurlo A; Marczak M; Jablonska S; Bollag W Int J Cancer; 1994 Apr; 57(1):81-5. PubMed ID: 7512078 [TBL] [Abstract][Full Text] [Related]
18. Chemotherapeutic evaluation of N-(4-hydroxyphenyl) retinamide-O-glucuronide in the rat mammary tumor model. Abou-Issa H; Curley RW; Panigot MJ; Tanagho SN; Sidhu BS; Alshafie GA Anticancer Res; 1997; 17(5A):3335-9. PubMed ID: 9413168 [TBL] [Abstract][Full Text] [Related]
19. Lack of an effect of dietary retinoids in chemical carcinogenesis of the mouse mammary gland: inverse relationship between mammary tumor cell anaplasia and retinoid efficacy. Welsch CW; DeHoog JV; Moon RC Carcinogenesis; 1984 Oct; 5(10):1301-4. PubMed ID: 6237806 [TBL] [Abstract][Full Text] [Related]
20. Activity of D-glucarate analogues: synergistic antiproliferative effects with retinoid in cultured human mammary tumor cells appear to specifically require the D-glucarate structure. Curley RW; Humphries KA; Koolemans-Beynan A; Abou-Issa H; Webb TE Life Sci; 1994; 54(18):1299-303. PubMed ID: 8190001 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]